Physician
Retina Specialists of Southern Arizona PLLC
Retina Specialists of Southern Arizona PLLC was paid $519K by Medicaid between Jan 2018 and Nov 2024, across 14 billing codes. Its largest line is 92014, Ophthalmological services: medical examination and evaluation, comprehensive, established patient — 25% of everything it billed.
33Billing provider infoRETINA SPECIALISTS OF SOUTHERN ARIZONA PLLC
TUCSON, AZ 85712
TUCSON, AZ 85712
33aNPI1902037310assigned 08/03/2009
33bProvider typeOphthalmology Physician
28Total paid$519K
24GClaims14,581
24DCodes billed14
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in Arizona
Rank by total paid#17 of 78
Median peer was paid$44K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,546 | $62K | |
| 2019 | 2,822 | $79K | |
| 2020 | 1,787 | $70K | |
| 2021 | 2,552 | $100K | |
| 2022 | 2,159 | $92K | |
| 2023 | 1,688 | $68K | |
| 2024incomplete | 1,027 | $49K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 25% | 1,992 | 1,783 | $132K |
| 67028 | Intravitreal injection of a pharmacologic agent | 21% | 2,076 | 1,796 | $108K |
| 92134 | 17% | 4,477 | 3,960 | $87K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 14% | 1,772 | 1,580 | $74K |
| 92226 | 5.1% | 1,982 | 1,067 | $26K | |
| 92201 | 4.8% | 1,190 | 833 | $25K | |
| J9035 | Injection, bevacizumab, 10 mg | 4.6% | 336 | 297 | $24K |
| J0178 | Injection, aflibercept, 1 mg | 2.1% | 15 | 12 | $11K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 2.0% | 101 | 100 | $10K |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 2.0% | 15 | 13 | $10K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.2% | 82 | 55 | $6K |
| 92202 | <1% | 378 | 353 | $3K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGONZALEZ, JACKELIN (MANAGER)